Biomed Detailed Program

8/7/2019 Biomed Detailed Program

1/9


2/9

2

MONDAY, May 23, 2011 (cont.)

12:10-

14:10Breakout Sessions (cont.)

Technology Transfer Panel I Hall E

BENCH TO BEDSIDE: CHALLENGES, OPPORTUNITIES, AND BEST OF CLASS PRACTICES

Moderator: Mr. Benjamin Soffer, T3, Technion R&D Foundation, Technology Transfer Office, Israel

PANEL DISCUSSION:

Dr. Robert Zivin, Senior Director, Corporate Office of Science & Technology (COSAT), Johnson & Johnson,USA

Dr. Konstantinos Kaloulis, External Opportunities In Licensing Manager, Merck Serono, Switzerland

Dr. Eli Hazum, General Partner, Medica Venture Partners, Israel

Mr. Amir Naiberg, CEO, Yeda, Israel

Mr. Josh Hexter, Executive Director, Corporate In Licensing, BioLineRx Ltd, Israel

Dr. Michal Roll, Director, Division of Research & Development, Tel-Aviv Sourasky Medical Center, Israel

Mr. Yonatan Regev, Manager of Higher Education and R&D Sector, Ministry of Finance, Israel

14:10-

15:10Lunch Break

15:10-

16:00Keynote Lecture Hall A

THE PAST, PRESENT AND FUTURE OF CARDIOVASCULAR TRANSLATIONAL MEDICINE RESEARCH

Dr. Gianni Gromo, Executive Senior VP, Global Head CV-Metabolism, Hoffmann-La Roche, Switzerland

16:00-

16:30Coffee Break

Breakout Sessions

Company Presentations Hall A

MEDICAL DEVICE

Company Presentations Hall B

BIOPHARMA

16:30-16:50 BioCep, Ltd. 16:30-16:50 TransPharma Medical, Ltd.

16:50-17:10 Discover Medical Devices 16:50-17:10 Dynamix Pharmaceuticals

17:10-17:30 NanoPass Technologies, Ltd. 17:10-17:30 Procognia (Israel) Ltd.

17:30-17:50 CollPlant, Ltd. 17:30-17:50 Compugen, Ltd.

17:50-18:10 Neetour Medical 17:50-18:10 BiondVax Pharmaceuticals, Ltd.

18:10-18:30 Medasense Biometrics, Ltd. 18:10-18:30 Immunovative Therapies, Ltd.

Seminar: DIGITAL/MOBILE HEALTH Hall CModerator: Dr. Benny Zeevi, Managing General Partner, DFJ Tamir Fishman Ventures, Israel

GLOBAL OPPORTUNITIES WITH MOBILE HEALTH

Dr. Talya Miron-Shatz, Wharton Business School, University of Pennsylvania, USA

DIGITAL AND MOBILE ENGAGEMENT: TRANSFORMATION OF MEDICAL MARKETING COMMUNICATIONS

Dr. Steven R. Peskin, Executive Vice President & Chief Medical Officer, MediMedia, USA

FDA'S EVOLVING REGULATION OF MOBILE HEALTH

Mr. Bradley Merrill Thompson, Epstein Becker & Green P.C., USA

NEW BUSINESS MODELS AND STAKEHOLDERS IN MOBILE HEALTH

Mr. Claudio Yarza, Partner, Pricewaterhouse-Coopers, Israel

DALLAS LEIPZIG IN ASSOCIATION WITH ILSI Hall D

16:30-16:45: VENTRICULAR ASSIST DEVICES: WHAT IS NEEDED TO INNOVATE AND BE SUCCESSFUL,

Dr. William Cohn, Director of Minimally Invasive Surgical Technology, Texas Heart Institute, St. Luke'sHospital, USA

16:45-17:00: TBA

17:00-17:15:TBA

17:15-17:55: Company Presentations

Enopace

17:55-18:30: Panel Discussion


3/9

3

MONDAY, May 23, 2011 (cont.)

16:30-


Technology Transfer Session I: MEDICAL DEVICES & BIOLOGICAL TOOLS Hall E

Moderator: Dr. Zeev Weinfeld, CEO, Ramot at Tel Aviv University, Ltd, Israel

Yeda R&D Co., Ltd, Weizmann Institute of ScienceHUMAN-MACHINE INTERFACE: NASAL FLOW DEVICE CONTROLLER

Prof. Noam Sobal

(Presented by Dr. Ruth Ben-Yakar)

Tel Hashomer Medical Research, Infrastructure and Services, Ltd. Chaim Sheba Medical Center

SHEBA MEDICAL CENTER: A NOVEL DEVICE FOR OBJECTIVE CHROMATIC PERIMETRY ANALYSIS

Dr.Ygal Rotenshtriech

T3, TechnionIsrael Institute of Technology

HOLOGRAPHIC NEURO-PROSTHESES

Dr. Shy Shoham

BioRap Technologies, Ltd.

The Technology Transfer Company of the Rappaport Research Institute,TechnionMETHODS OF IMPROVING THE EFFICACY OF FAT TRANSPLANTATION

Dr. Saher Hamed

Fund for Medical Research Development of Infrastructure & Health ServicesRambam Medical Center

NOVOGATE MEDICAL: TRANSAPICAL CARDIAC ACCESS

Mr. Ziv Belsky

Ramot at Tel Aviv University, Ltd.

PREDICTING AND VALIDATING NOVEL ANTI-CANCER METABOLIC TARGETS

Prof. Eytan Ruppin

Hadasit Medical Research Services & Developments, Ltd.The Technology Transfer Company of Hadassah

University Hospitals

A REVOLUTIONARY EXTERNAL UPPER AIRWAY OPENING DEVICE COMBINED WITH A CERVICAL COLLAR

Mr. Stuart Bernstein

Bar-Ilan Research and Development Company, Ltd.

USAGE OF CORNEA FOR BIOMEDICAL SENSING AND FOR VISION

Prof. Zeev Zalevsky

Carmel-Haifa University Economic Corp

THE BIOHUG VEST: ADVANCED CALMING TECHNOLOGY

Mr. Andrew Schiffmiller

Mor Research ApplicationsClalit Health Services

MD-LOGIC ARTIFICIAL PANCREAS SYSTEM

Mr. Eran Atlas

Tel-Aviv Sourasky Medical CenterAUTOMATED DETECTION OF MISSTEPS AND NEAR FALLS

Prof. Jeff Hausdorf

19:00-

21:00ILSI Welcome Cocktail


4/9

4

TUESDAY, May 24, 2011

09:00-


Prof. Stanley Fischer, Governor of the Bank of Israel, Israel

09:30-


CELL SIGNALING BY RECEPTOR TYROSINE KINASES: FROM BASIC PRINCIPLES TO CANCER THERAPY

Prof. Yossi Schlessinger, Chairman Department of Pharmacology, Yale University School of Medicine,Founder/ Co-Founder, SUGEN, Plexxikon, Koltan, USA

10:20-


HOW TECHNOLOGY SAVED HEALTHCARE

Dr. Stephen N. Oesterle, Senior Vice President, Medicine and Technology, Medtronic Inc., USA

11:10-

11:30Coffee Break Sponsored by

11:30-

13:30Breakout Sessions


MEDICAL DEVICE


BIOPHARMA

11:30-11:50 ElMindA Ltd. 11:30-11:50 Vaxil Biotherapeutics Ltd.11:50-12:10 Real Imaging 11:50-12:10 D-Pharm Ltd.

12:10-12:30 D. Medical Industries Ltd. 12:10-12:30 Lycored Ltd.

12:30-12:50 Apos Medical and Sports

Technologies Ltd.

12:30-12:50 KAHR Medical

12:50-13:10 BrainsGate Ltd. 12:50-13:10 Oramed Pharmaceuticals

13:10-13:30 MetaCure Limited 13:10-13:30 Biokine Therapeutics Ltd.

Seminar: DISCOVERY & DEVELOPMENT OF BIOLOGICS Hall C

Moderator: Dr. Yael Weiss, Director, Global Scientific Affairs, Merck & Co., Israel

Dr. Ralf Schumacher, VP Biologics Research & pRED Center Manager, Pharma Research and Early

Development (pRED), Germany

Dr. Robert Kastelein, Vice President, Biologics Strategy, Merck & Co., Inc., USA

Dr. Aya Jakobvitz, CEO, Kite Pharma, Inc., USADr. Trevor J. Hallam, CSO, Sutro Biopharma, USA

Seminar: Hall D

THE DIRECTION OF HEALTHCARE IN THE US: A FORWARD LOOKING VIEW FROM THE CLEVELAND CLINIC,

ONE OF THE UNITED STATES PREMIER HEALTHCARE PROVIDERS

11:30: Welcome and Introduction: Mr. Chris Coburn, Executive Director Cleveland Clinic Innovations, USA

11:40: FROM HOSPITAL TO HOME: THE EVOLUTION OF REMOTE PATIENT MONITORING AND

MANAGEMENT

Dr. Eiran Z. Gorodeski, Section of Heart Failure and Cardiac Transplantation Medicine, Cleveland Clinic,

USA

12:15: FROM DETECTION TO PREDICTION: SHIFTING PARADIGMS IN DIAGNOSTIC MEDICINE

Dr. Brian P. Griffin, The John and Rosemary Brown Chair in Cardiovascular Medicine-the Section of

Cardiovascular Imaging, Cleveland Clinic, USA

12:50: TRENDS IN NEUROMODULATION:CROSSING THE THRESHOLD FOR IMPLANT BASED THERAPIES

Dr. Andre Machado, Director of the Center for Neurological Restoration, Neurological Institute, Cleveland

Clinic, USA


5/9

5

TUESDAY, May 24, 2011 (cont.)

11:30-


Technology Transfer Panel II Hall E

SUCCESSSTORIES AND CHALLENGES IN TECHNOLOGY TRANSFER FROM ACADEMIAModerator: Dr. Einat Zisman, CEO, Hadasit, The Technology Transfer Company of Hadassah University

Hospitals, Israel

PANEL DISCUSSION:

Mrs. Shira Yair, CEO, ProtAb, Ltd., Israel

Dr. Noa Shelach, CEO, Campus-Bio, Israel

Mr. Moshe Tzabari, CEO, RegeneCure Ltd., Israel

Dr. Naomi Zak, CEO, SCTherapeutics, Ltd.,Van Leer Technology Ventures, Israel

Dr. Yaniv Dolev, CEO, Moebius Medical, Israel13:30-

14:30Lunch Break

14:30-

15:20

Keynote Lecture Hall A

INTENSE FOCUS TO DRIVE INNOVATION

Mr. Michael A. Mussallem,Chairman and CEO, Edwards Lifesciences, USA15:20-

15:50Coffee Break Sponsored by

15:50-



MEDICAL DEVICE


BIOPHARMA

15:50-16:10 EstimME, Ltd. 15:50-16:10 Andromeda Biotech, Ltd.

16:10-16:30 EarlySense 16:10-16:30 Macrocure, Ltd.

16:30-16:50 Medi-Tate, Ltd 16:30-16:50 Aposense, Ltd.

16:50-17:10 Neuronix Medical 16:50-17:10 Can-Fite BioPharma17:10-17:30 Alpha Omega Engineering 17:10-17:30 Pluristem Therapeutics, Inc.

17:30-17:50 Dia Cardio, Ltd. 17:30-17:50 HealOr, Ltd.

Seminar: ORPHAN DRUGS & DEVICES Hall C

Moderator: Barry Greene, President & Chief Operating Officer, Alnylam Pharmaceuticals, USA

Dr. Stephen Oesterle, Senior VP of Medicine & Technology, Medtronic Inc., USA

Dr. Robert Pacifici, Chief Scientific Officer, CHDI, USA

Dr. Rachel Humphrey, Vice President, Global Development Leader of YERVOY, Bristol-Myers Squibb, USA

Seminar: THE DIRECTION OF HEALTHCARE IN THE US (cont.) Hall D

15:50: Welcome Back: Chris Coburn, Executive Director Cleveland Clinic Innovations, USA

16:00: TOO MANY PATIENTS, TOO MUCH DATA HOW TO MANAGE THE OVERLOAD

Mr. Stephen McHale, CEO, Exployrs, USA

Dr. William Morris, Department of Hospital Medicine Cleveland Clinic and Manager of Medical Informatics

for eCleveland Clinic, USA

16:55: MEGATRENDS DRIVING HEALTHCARE INNOVATION

Moderator: Mr.Chris Coburn, Executive Director Cleveland Clinic Innovations, USA

Dr. Eiran Z. Gorodeski, Section of Heart Failure and Cardiac Transplantation Medicine Cleveland Clinic, USA

Dr. Brian P. Griffin, The John and Rosemary Brown Chair in Cardiovascular Medicine, Section of Cardio-

vascular Imaging, Cleveland Clinic, USA

Mr. Mark Low, Managing Director Global Cardio-vascular Innovation Center


6/9

6

Dr. Andre Machado, Director of the Center for Neurological Restoration, Neurological Institute, Cleveland

Clinic, USA

Mr. Stephen McHale, CEO, Exployrs, USA

Dr. William Morris, Department of Hospital Medicine Cleveland Clinic and Manager of Medical Informatics

for eCleveland Clinic, USA

TUESDAY, May 24, 2011 (cont.)

15:50-

17:50

Breakout Sessions (cont.)

Technology Transfer Session II: DRUG DELIVERY AND MOLECULAR MARKERS Hall E

Moderator: Mr. Yaakov Michlin, CEO, Yissum, Israel

GavishMigal Galilee Technology Center

NOVEL DESIGNED MARKERS FOR THE CHARACTERIZATION OF OXIDATIVE STRESS AND THEIR

APPLICATIONS

Prof. Jacob Vaya

Bar-Ilan Research and Development Company, Ltd.

NETWORK AS BIOMARKER IN OVARIAN CANCER PROGNOSIS

Dr. Sol Ephroni

Mor Research Applications

Clalit Health Services

LOW MICRO-RNA EXPRESSION LEVEL PREDICTS RELAPSE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

Dr. Smadar Avigad

YissumThe Technology Transfer Company of the Hebrew University of Jerusalem

USING A SUSTAINED RELEASE DELIVERY SYSTEM OF SIROLIMUS FOR HEAD AND NECK CANCER TREATMENT

Dr. Rakefet Czerninski

Tel-Aviv Sourasky Medical Center

GLAUCOMA SHUNT DEVICE

Prof. Adiel Barak

Tel Hashomer Medical Research, Infrastructure and Services, Ltd.

Chaim Sheba Medical CenterMI-RNA SIGNATURES FOR MELANOMA DISEASE MANAGEMENT: DIAGNOSIS AND TREATMENT

Dr. Gal Markel


QUANTIFICATION OF SPACE TIME FACIAL FEATURES AS DIAGNOSTIC TOOL FOR PARKINSON'S DISEASE

Mr. Shmuel Raz



AMD: NOVEL BIOMARKERS FOR AGE RELATED MACULAR DEGENERATION

Dr. Tamar AlonT3, Technion

Israel Institute of Technology

CASEIN NANOVEHICLES FOR ORAL DRUG DELIVERY: TARGETING GASTRIC CANCER AND BEYOND

Ms. Alina Shapira

A NEW UNIVERSAL DIAGNOSTIC METHOD FOR CANCER AND AUTOIMMUNITY

Prof. Arie Admon

Yeda R&D Co., Ltd, Weizmann Institute of Science

BIOMARKERS FOR MUSCLE INVASION IN BLADDER CANCER

Prof. Irun R. Cohen


7/9

7

(Presented by Dr. Shiraz Kalir)


8/9

8

WEDNESDAY, May 25, 2011

09:00-

09:20Greetings Hall A

Avi Hasson, Chief Scientist, Ministry of Industry, Trade and Labor, Israel

09:20-


CREATING A SUCCESSFUL MEDICAL PRODUCT ENTERPRISE

Mr. Al Mann, Chairman and CEO, MannKind Corporation, USA

10:10-

11:00

Keynote Lecture Hall A

PERSPECTIVES ON THE BIOPHARMACEUTICAL INDUSTRY - 2011 AND BEYONDDr. Garry Neil, Corporate Vice President, Corporate Office of Science and Technology (COSAT) Johnson &

Johnson, USA

11:00-

11:30Coffee Break

Sponsored by Johnson & Johnson, COSAT , Biosense Webster

11:30-



MEDICAL DEVICE


BIOPHARMA

11:30-11:50 BioControl Medical, Ltd. 11:30-11:50 Chiasma

11:50-12:10 LifeBond, Ltd. 11:50-12:10 NasVax, Ltd.

12:10-12:30 Microbot Medical, Ltd. 12:10-12:30 Prolor-Biotech, Inc.12:30-12:50 Exalenz Bioscience, Ltd. 12:30-12:50 CureTech, Ltd.

12:50-13:10 FlowMedic, Ltd. 12:50-13:10 Cell Cure Neurosciences, Ltd.

13:10-13:30 Cardiogal, Ltd. 13:10-13:30 BioImage MRI Research & Consulting

New Technology Session Sponsored by Hall C

Technology Transfer Session III: PHARMACEUTICALS AND STEM CELLS Hall E

Moderator: Mr. Joseph Nathan, Director of New Ventures, T3-Technion Technology Transfer Office, Israel


USING THE CELL-SUBSTRATE IMPEDANCE SENSING SYSTEM FOR THE EVALUATION OF MACROPHAGE PRO-

AND ANTI-INFLAMMATORY RESPONSES

Dr. Amiram Ariel

Yeda R&D Co., Ltd, Weizmann Institute of Science

MONOCLONAL ANTIBODIES AS POTENT INHIBITORS OF METALLOPROTIENASES

Prof. Irit Sagi

Tel-Aviv Sourasky Medical Center

ANTI-CD24 FOR CANCER TREATMENT

Prof. Nadir Arber

Bar-Ilan Research and Development Company, Ltd.NOVEL NANO-SIZED CYCLIC PEPTIDES AS POTENTIAL THERAPEUTICS FOR MULTIPLE SCLEROSIS

Dr. Shai Rahimipour



HYPER IL-6: NOVEL TISSUE PROTECTIVE AND REGENERATIVE MOLECULE

Dr. Tamar Alon


9/9

9

WEDNESDAY, May 25, 2011 (cont.)

11:30-


Technology Transfer Session III: PHARMACEUTICALS AND STEM CELLS (cont.) Hall E

GavishMigal Galilee Technology Center

TARGETED MICRO-PARTICLES FOR ATTRACTION AND INDUCTION OF SPECIFIC INNATE IMMUNE RESPONSE

Prof. Jacob Pitcovski

Tel Hashomer Medical Research, Infrastructure and Services, Ltd. Chaim Sheba Medical Center

NOVEL COMPOSITIONS FROM SHEBA MEDICAL CENTER

Dr. Sylvie Luria

BioRap Technologies, Ltd.The Technology Transfer Company of the Rappaport Research Institute,

TechnionENHANCING IMMUNE RESPONSE IN AGING

Prof. Doron Melamed

YissumThe Technology Transfer Company of the Hebrew University of Jerusalem

NOVEL COMPOUNDS FOR THE TREATMENT OF OBESITY

Dr. Yosefa AvrahamB.G.Negev Technologies, Ltd.Technology Transfer Company of Ben-Gurion University

THE MITOCHONDRIAL PROTEIN VDAC AS A NOVEL TARGET FOR CANCER THERAPY

Prof. Varda Shoshan-Barmatz

A NOVEL ANTI CPLA2 ANTISENSE FOR THE TREATMENT OF INFLAMMATORY DISEASESAND CANCER

ASSOCIATED INFLAMMATIONS

Prof. Rachel Levy

Ramot at Tel Aviv University, Ltd.

STEM CELLS AS A NOVEL DRUG DELIVERY APPROACH FOR THE TREATMENT OF NEUROLOGICAL DISEASES

Prof. Daniel Offen

NOVEL ANTIPSYCHOTICS WITH PUTATIVE POSITIVE MODULATORY GLUTAMATERGIC ACTIVITY

Prof. Abraham Weizman13:30-

14:30Lunch Break

14:30-

15:30Closing Panel Hall A

GLOBAL MANAGEMENT LOCAL COMPANY

Moderator: Dr. Dalia Megiddo, 7HealthVentures, Israel

Mr. Allen Hill, CEO, Visioncare, Israel

Mr. Fred Price, CEO, Chiasma, Israel

Prof. Dror Harats, CEO, VBL, Israel

Dr. Yael Margolin, CEO, Gamida-Cell, Israel15:30-

16:20Closing Event & Awards Ceremony Hall A

Biomed Detailed Program

Documents

Transcript of Biomed Detailed Program